IP Verse

Migalastat Formulations Having Improved Pharmacokinetics

Patent No. EP4385509 (titled "Migalastat Formulations Having Improved Pharmacokinetics") was filed by Amicus Therapeutics on May 31, 2023. The application was issued on Sep 3, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLERJun 3, 2026BRAND MURRAY FULLER
HAMM & WITTKOPPJun 2, 2026HAMM & WITTKOPP
TEVA PHARMACEUTICALSJun 2, 2026D YOUNG
MAIWALDJun 1, 2026MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4385509

AMICUS THERAPEUTICS
Application Number
EP23176366A
Filing Date
May 31, 2023
Status
Granted And Under Opposition
Aug 1, 2025
Publication Date
Sep 3, 2025
External Links
Slate, Register , Google Patents